1
|
Bos-Roubos A, van Leeuwen H, Wingbermühle E, van den Bosch L, Ossewaarde L, Taal W, de Graaff L, Egger J. Cognition and behavior in adults with neurofibromatosis type 1. Front Neurol 2024; 15:1476472. [PMID: 39677862 PMCID: PMC11638057 DOI: 10.3389/fneur.2024.1476472] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/05/2024] [Accepted: 10/31/2024] [Indexed: 12/17/2024] Open
Abstract
Background Neurofibromatosis Type 1 (NF1) is a congenital neurocutaneous disorder. As NF1 is incurable and presents with a wide range of physical and mental symptoms, knowledge of neurocognitive and behavioral functioning can be an important aid in understanding their functional impact, and developing treatment options. To date, studies in children with NF1 have shown dysfunction in several domains, but much less is known about cognition and behavior in adults with NF1. The present study describes the neuropsychological phenotype of adults with NF1 based on comprehensive clinical examination of cognition and behavior across multiple functions. Methods Participants were 62 adults with NF1 (mean age 38.2 years; SD 13.4). All underwent individual clinical neuropsychological assessment at the Center of Excellence for Neuropsychiatry as part of regular care. Scores on all individual measures were standardized into z-scores based on the corresponding normative group data. The proportions of mean z-scores in the NF1 study group were calculated according to cut-off points (±1 to ±1.5 SD; > ±1.5 SD) and compared to the expected proportions in the normal population distribution. Cognition and behavior was tested against population means constructed by bootstrapping. Results Performance on the cognitive measures oral reading speed, visuospatial copying, visuospatial immediate recall, visual learning/imprinting, and visual memory immediate recall in the NF1 group were lower than normative means. The behavioral measures indicated higher levels of dysfunction, including psychopathology. The proportions of the NF1 study group with lower cognitive performance and higher levels of behavioral dysfunction were larger than in the normal population distributions. In addition, domain-level results revealed that intelligence, attention/speed, memory, and social cognition reflect cognitive dysfunction. Moreover, levels of emotion perception problems, experienced executive dysfunction, internalizing psychopathology (e.g., anxiety, depression), and severe fatigue were significantly higher compared to the simulated population sample. The mean level of emotion regulation (coping strategies) did not differ significantly from the population. Conclusion Identified cognitive and behavioral dysfunction in multiple domains indicates high vulnerability in adults with NF1 and underscores the importance of individualized neuropsychological assessment and treatment. Further research on the relationships between cognition and behavior (including fatigue) in NF1 is warranted.
Collapse
Affiliation(s)
- Anja Bos-Roubos
- Centre of Excellence for Neuropsychiatry, Vincent van Gogh Institute for Psychiatry, Venray, Netherlands
- Donders Institute for Brain, Cognition and Behaviour, Radboud University, Nijmegen, Netherlands
- Center for Adults With Rare Genetic Syndromes, Erasmus University Medical Center, Rotterdam, Netherlands
| | - Hanneke van Leeuwen
- Centre of Excellence for Neuropsychiatry, Vincent van Gogh Institute for Psychiatry, Venray, Netherlands
- Donders Institute for Brain, Cognition and Behaviour, Radboud University, Nijmegen, Netherlands
- Dialexis, Training Institute for Dialectical Behavior Therapy, Nijmegen, Netherlands
| | - Ellen Wingbermühle
- Centre of Excellence for Neuropsychiatry, Vincent van Gogh Institute for Psychiatry, Venray, Netherlands
- Donders Institute for Brain, Cognition and Behaviour, Radboud University, Nijmegen, Netherlands
- Center for Adults With Rare Genetic Syndromes, Erasmus University Medical Center, Rotterdam, Netherlands
- Department of Human Genetics, Radboud University Medical Centre, Nijmegen, Netherlands
| | | | - Lindsey Ossewaarde
- Eikenboom Psychosomatic Medicine, Altrecht Mental Health Institute, Zeist, Netherlands
| | - Walter Taal
- Department of Neurology/Neuro-oncology, Erasmus MC Cancer Institute, University Medical Center, Rotterdam, Netherlands
- ENCORE-Dutch Center of Reference for Neurodevelopmental Disorders, Rotterdam, Netherlands
| | - Laura de Graaff
- Center for Adults With Rare Genetic Syndromes, Erasmus University Medical Center, Rotterdam, Netherlands
- Department of Internal Medicine, Erasmus University Medical Center, Rotterdam, Netherlands
- Department of Internal Medicine, Radboud University Medical Center, Nijmegen, Netherlands
| | - Jos Egger
- Centre of Excellence for Neuropsychiatry, Vincent van Gogh Institute for Psychiatry, Venray, Netherlands
- Donders Institute for Brain, Cognition and Behaviour, Radboud University, Nijmegen, Netherlands
- Center for Adults With Rare Genetic Syndromes, Erasmus University Medical Center, Rotterdam, Netherlands
- Department of Human Genetics, Radboud University Medical Centre, Nijmegen, Netherlands
- Stevig Specialized and Forensic Care for People With Intellectual Disabilities, Dichterbij, Oostrum, Netherlands
| |
Collapse
|
2
|
Slevin H, Kehinde F, Begum-Ali J, Ellis C, Burkitt-Wright E, Green J, Johnson MH, Pasco G, Charman T, Jones EJH, Garg S. Developmental trajectories in infants and pre-school children with Neurofibromatosis 1. Mol Autism 2024; 15:45. [PMID: 39407332 PMCID: PMC11481376 DOI: 10.1186/s13229-024-00621-5] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/29/2024] [Accepted: 09/11/2024] [Indexed: 10/19/2024] Open
Abstract
BACKGROUND Children with Neurofibromatosis 1 (NF1) show cognitive, behavioural and social differences compared to their peers. However, the age and sequence at which these differences begin to emerge is not fully understood. This prospective cohort study examines the cognitive, behavioural, ADHD trait and autism symptom development in infant and pre-school children with NF1 compared with typically developing (TD) children without a family history of neurodevelopmental conditions. METHODS Data from standardised tests was gathered at 5, 10, 14, 24 and 36 months of age (NF1 n = 35, TD n = 29). Developmental trajectories of cognitive (Mullen Scales of Early Learning, MSEL) and adaptive behavioural (Vineland Adaptive Behavior Scales, VABS) development from 5 to 36 months were analysed using linear mixed modelling. Measures of ADHD (Child Behavior Checklist) and autism traits (ADOS-2, BOSA-MV and ADI-R) were assessed at 24 and 36 months. RESULTS The developmental trajectory of cognitive skills (all domains of the MSEL) and behavioural skills (four domains of the VABS) differed significantly between NF1 and TD groups. Post-hoc tests demonstrated that the NF1 participants scored significantly lower than TD participants at 24 months on all MSEL and VABS domains. The NF1 cohort demonstrated higher mean autism and ADHD traits at 24 months and 14% of the NF1 cohort met a research diagnostic classification for autism at 36 months. LIMITATIONS The study has a relatively small sample size due to variable retention and rolling recruitment. Due to limitations imposed by the COVID-19 pandemic, we utilised the Brief Observation of Symptoms of Autism for Minimally Verbal children (BOSA-MV) for some participants, which was administered online and may not gather as accurate a picture of traits as ADOS-2. The BOSA-MV was utilised for 41% of participants with NF1 at 36 months compared to 11% at 24 months. This may explain the reduction in the percentage of children with NF1 that met autism criteria at 36 months. CONCLUSIONS By 24 months of age, the NF1 cohort show lower cognitive skills and adaptive behaviour and higher levels of autism and ADHD traits as compared to TD children. This has implications for developmental monitoring and referral for early interventions. TRIAL REGISTRATION Not applicable.
Collapse
Affiliation(s)
- Hannah Slevin
- Division of Psychology and Mental Health, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, UK
| | - Fiona Kehinde
- Division of Psychology and Mental Health, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, UK
| | - Jannath Begum-Ali
- Centre for Brain and Cognitive Development and Department of Psychological Sciences, Birkbeck, University of London, London, UK
| | - Ceri Ellis
- Division of Psychology, Communication and Human Neuroscience, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, UK
| | - Emma Burkitt-Wright
- Manchester Centre for Genomic Medicine, Manchester University NHS Foundation Trust, Manchester, UK
- Faculty of Biology, Medicine and Health, University of Manchester, Manchester, UK
| | - Jonathan Green
- Division of Psychology and Mental Health, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, UK
- Harrington Building, Royal Manchester Children's Hospital, Oxford Rd, Manchester, M13 9WL, UK
| | - Mark H Johnson
- Centre for Brain and Cognitive Development and Department of Psychological Sciences, Birkbeck, University of London, London, UK
- Department of Psychology, University of Cambridge, Cambridge, UK
| | - Greg Pasco
- Psychology Department, Institute of Psychiatry, King's College London, Psychology & Neuroscience, London, UK
| | - Tony Charman
- Psychology Department, Institute of Psychiatry, King's College London, Psychology & Neuroscience, London, UK
| | - Emily J H Jones
- Centre for Brain and Cognitive Development and Department of Psychological Sciences, Birkbeck, University of London, London, UK
| | - Shruti Garg
- Division of Psychology and Mental Health, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, UK.
- Harrington Building, Royal Manchester Children's Hospital, Oxford Rd, Manchester, M13 9WL, UK.
| |
Collapse
|
3
|
Vernet M, Ducrot S, Chaix Y. A Systematic Review on Visual-Processing Deficits in Neurofibromatosis Type 1: What Possible Impact on Learning to Read? Dev Neuropsychol 2024; 49:111-137. [PMID: 38469855 DOI: 10.1080/87565641.2024.2326151] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/22/2023] [Accepted: 02/27/2024] [Indexed: 03/13/2024]
Abstract
This systematic review aimed to examine the possible implication of visual-perceptual, visuo-attentional and oculomotor processing in the reading deficits frequently experienced by children with Neurofibromatosis type 1 (NF1), as previously shown in dyslexia. Using PRISMA methodological guidelines, we examined 49 studies; most of these reported visual-processing deficits in this population, raising the importance of directly studying the visuo-perceptual and visuo-attentional processes and eye-movement control involved in the learning-to-read process in NF1. The discussion provides a reflection for a better understanding of how visual-processing skills interact with reading deficits in NF1, as well as new avenues for their screening and care.
Collapse
Affiliation(s)
- Marie Vernet
- Aix Marseille Univ, CNRS, LPL, Aix-en-Provence, France
- Centre de jour enfants, Centre hospitalier de Digne-les-Bains, Digne-les-Bains, France
- TONIC, Toulouse NeuroImaging Center, Université de Toulouse, Inserm, UPS, Toulouse, France
| | | | - Yves Chaix
- TONIC, Toulouse NeuroImaging Center, Université de Toulouse, Inserm, UPS, Toulouse, France
- Neuropediatric Department, Toulouse-Purpan University Hospital, Toulouse, France
| |
Collapse
|
4
|
Zhan S, Guo J. How household chaos affects social withdrawal of rural children: the indirect role of executive function and receptive language ability. Front Psychol 2023; 14:1212426. [PMID: 37469898 PMCID: PMC10352795 DOI: 10.3389/fpsyg.2023.1212426] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/26/2023] [Accepted: 06/14/2023] [Indexed: 07/21/2023] Open
Abstract
Executive function (EF) and receptive language ability play an important role in the relationship between household chaos and social withdrawal. Young children are neglected in household chaos research and suffer from the negative outcomes of households in China. However, few studies have focused on the relationship between household chaos and social withdrawal in young Chinese children and the chain mediating effect of EF and receptive language ability. This study included 922 preschool-age children (62.58 ± 8.03 months) and their primary caregivers and their teachers were recruited from 21 rural preschools in Guangdong Province in China. Our results show a positive direct effect of household chaos and social withdrawal. Furthermore, an indirect sequential effect of household chaos and social withdrawal on EF and receptive language ability was found. Our findings (a) highlight the significance of paying more attention to household chaos and revealing a better understanding of the effect of EF and receptive language ability on households at an early age and (b) indicate that interventions should be provided to improve the home environment when children are young.
Collapse
Affiliation(s)
- Shuwei Zhan
- School of Education, Central China Normal University, Wuhan, Hubei Province, China
| | - Jinna Guo
- Shantou Teacher Development Center, Shantou, Guangdong Province, China
| |
Collapse
|
5
|
Fournier H, Calcagni N, Morice-Picard F, Quintard B. Psychosocial implications of rare genetic skin diseases affecting appearance on daily life experiences, emotional state, self-perception and quality of life in adults: a systematic review. Orphanet J Rare Dis 2023; 18:39. [PMID: 36823650 PMCID: PMC9951542 DOI: 10.1186/s13023-023-02629-1] [Citation(s) in RCA: 4] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/29/2022] [Accepted: 02/06/2023] [Indexed: 02/25/2023] Open
Abstract
BACKGROUND Since the beginning of human genetic research, there are very few publications sharing insights of the negative impact of rare genetic skin diseases (RGSD) on patients' experiences. This systematic review assessed the psychosocial implications of these conditions in terms of daily life experiences, emotional state, self-perception, and Quality of Life (QoL). METHODOLOGY A systematic review was carried out on albinism, neurofibromatosis type 1 (NF1), birthmarks and inherited ichthyosis. The PubMed, Scopus, PsycArticle, PsychInfo, Psychology and Behavioral Sciences Collection, and SOCindex databases were queried. Inclusion criteria were adult patients with one of these RGSDs. Simple descriptive statistics and qualitative content analysis were conducted to summarize the main results reported by the authors. RESULTS Of the 9987 articles retrieved, 48 articles were included: albinism (16), NF1 (16), inherited ichthyosis (10), birthmarks (6). The majority of the studies on albinism were conducted in Africa. Twenty-seven studies quantitatively assessed diverse psychological parameters: 13 showed a significant impact of the disease on QoL, five on emotional state, two on self-representation and two others on psychiatric comorbidities. Disease severity and visibility were good predictors of QoL (except for albinism). Body image and appearance concerns were also associated with QoL and emotional state. The 19 qualitative studies highlighted recurring themes across each of these diseases: discrimination and stigma during childhood and adolescence, discomfort in social interactions, guilt of transmission, the importance of social support from family and friends, altered daily life functioning, altered romantic and sex life, limited academic and professional aspirations, lack of interest and support from the medical field, and the unpredictability of the evolution of the disease. The only two mixed-method studies in this review were unable to contribute to any inferential analyses but could corroborate some of the qualitative findings. CONCLUSION These results showed that RGSDs have a significant impact on different aspects of patients' lives. This review has demonstrated that there is a real need for support systems for patients with these diseases. Such systems should be developed to provide them with necessary information and to guide them through an appropriate care pathway.
Collapse
Affiliation(s)
- Hugo Fournier
- Laboratoire de Psychologie (LabPsy) EA4139, Univ. Bordeaux, 3 ter Place de la Victoire, Bâtiment A - 1er étage, 33000 Bordeaux, France
| | | | | | - Bruno Quintard
- Laboratoire de Psychologie (LabPsy) EA4139, Univ. Bordeaux, 3 ter Place de la Victoire, Bâtiment A - 1er étage, 33000 Bordeaux, France
| |
Collapse
|
6
|
Garg S, Wan MW, Begum-Ali J, Kolesnik-Taylor A, Green J, Johnson MH, Jones E. Early Developmental Trajectories in Infants With Neurofibromatosis 1. Front Psychol 2022; 13:795951. [PMID: 35936291 PMCID: PMC9355323 DOI: 10.3389/fpsyg.2022.795951] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/15/2021] [Accepted: 06/20/2022] [Indexed: 11/13/2022] Open
Abstract
Objective To examine the trajectories of cognitive, motor and behavioural development in infants with NF1 compared to infants without a family history of neurodevelopmental difficulties. Study design Infants with NF1 and low-risk controls were recruited from 5 months of age and followed longitudinally. Data from standardised tests was gathered at 5, 10 and 14 months and developmental trajectories of motor, language, behaviour, sleep, social development and parent-infant interaction were examined. Linear mixed modelling was used to estimate group differences in cognitive and behavioural measures over time. Results No group differences were observed on Mullen Scale of Early Learning, overall adaptive functioning, temperament or behavioural measures. There were no group differences observed on measures of social communication or parent-infant interaction. Over the course of development, the NF1 group slept less and took more time to settle to sleep as compared to the control group. Maternal education was significantly associated with cognitive and behavioural developmental outcomes in both groups. Conclusion Cognitive, social and behavioural impairments are a cause of significant functional morbidity in children with NF1. This report is the first study to investigate the trajectories of cognitive, motor and behavioural development in infancy in NF1. Our results demonstrate that overall cognitive and behavioural developmental trajectories of the NF1 group in the infancy period are similar to controls. Given previous reports of delayed development in the NF1 cohort by 40 months, early clinical interventions strategies to promote sleep hygiene may be beneficial to optimise developmental outcomes.
Collapse
Affiliation(s)
- Shruti Garg
- Division of Neuroscience and Experimental Psychology, Manchester Academic Health Science Centre, University of Manchester, Manchester, United Kingdom
- Royal Manchester Children’s Hospital, Central Manchester University Hospitals NHS Foundation, Manchester, United Kingdom
| | - Ming Wai Wan
- Division of Psychology and Mental Health, School of Health Sciences, Manchester Academic Health Science Centre, University of Manchester, Manchester, United Kingdom
| | - Jannath Begum-Ali
- Centre for Brain and Cognitive Development and Department of Psychology, Birkbeck, University of London, London, United Kingdom
| | - Anna Kolesnik-Taylor
- MRC Cognition and Brain Sciences Unit, University of Cambridge, Cambridge, United Kingdom
| | - Jonathan Green
- Division of Neuroscience and Experimental Psychology, Manchester Academic Health Science Centre, University of Manchester, Manchester, United Kingdom
- Royal Manchester Children’s Hospital, Central Manchester University Hospitals NHS Foundation, Manchester, United Kingdom
| | - Mark H. Johnson
- Centre for Brain and Cognitive Development and Department of Psychology, Birkbeck, University of London, London, United Kingdom
- Department of Psychology, University of Cambridge, Cambridge, United Kingdom
| | - Emily Jones
- Centre for Brain and Cognitive Development and Department of Psychology, Birkbeck, University of London, London, United Kingdom
| |
Collapse
|
7
|
Foy AMH, Hudock RL, Shanley R, Pierpont EI. Social behavior in RASopathies and idiopathic autism. J Neurodev Disord 2022; 14:5. [PMID: 35021989 PMCID: PMC8753327 DOI: 10.1186/s11689-021-09414-w] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 01/04/2021] [Accepted: 12/24/2021] [Indexed: 11/22/2022] Open
Abstract
Background RASopathies are genetic syndromes that result from pathogenic variants in the RAS-MAPK cellular signaling pathway. These syndromes, which include neurofibromatosis type 1, Noonan syndrome, cardiofaciocutaneous syndrome, and Costello syndrome, are associated with a complex array of medical and behavioral health complications. Despite a heightened risk for social challenges and autism spectrum disorder (ASD), few studies have compared different aspects of social behavior across these conditions. It is also unknown whether the underlying neuropsychological characteristics that contribute to social competence and socially empathetic (“prosocial”) behaviors differ in children with RASopathies as compared to children with nonsyndromic (i.e., idiopathic) ASD. Methods In this cross-sectional, survey-based investigation, caregivers of preschool and school-aged children with RASopathies (n = 202) or with idiopathic ASD (n = 109) provided demographic, medical, and developmental information about their child, including psychiatric comorbidities. For children who were able to communicate verbally, caregivers also completed standardized rating scales to assess social competence and empathetic behavior as well as symptoms of hyperactivity/inattention and emotional problems. Results As compared to children with idiopathic ASD, children with RASopathies were rated as demonstrating more resilience in the domain of empathy relative to their overall social competence. Similarities and differences emerged in the psychological factors that predicted social behavior in these two groups. Stronger communication skills and fewer hyperactive-impulsive behaviors were associated with increased empathy and social competence for both groups. Greater emotional challenges were associated with lower social competence for children with RASopathies and stronger empathy for children with idiopathic ASD. Among children with RASopathy and a co-occurring ASD diagnosis, socially empathetic behaviors were observed more often as compared to children with idiopathic ASD. Conclusions Findings suggest that the development of social behavior among children with RASopathies involves a distinct pattern of strengths and weaknesses as compared to a behaviorally defined disorder (idiopathic ASD). Identification of areas of resilience as well as behavioral and social challenges will support more targeted intervention. Supplementary Information The online version contains supplementary material available at 10.1186/s11689-021-09414-w.
Collapse
Affiliation(s)
- Allison M H Foy
- Department of Pediatrics, Division of Clinical Behavioral Neuroscience, University of Minnesota Medical School, 2025 East River Parkway, Minneapolis, MN, 55414, USA.,Department of Educational Psychology, University of Wisconsin-Madison, Madison, USA
| | - Rebekah L Hudock
- Department of Pediatrics, Division of Clinical Behavioral Neuroscience, University of Minnesota Medical School, 2025 East River Parkway, Minneapolis, MN, 55414, USA
| | - Ryan Shanley
- Biostatistics Core, Masonic Cancer Center, University of Minnesota, Minneapolis, USA
| | - Elizabeth I Pierpont
- Department of Pediatrics, Division of Clinical Behavioral Neuroscience, University of Minnesota Medical School, 2025 East River Parkway, Minneapolis, MN, 55414, USA.
| |
Collapse
|
8
|
Klein-Tasman BP, Lee K, Thompson HL, Janusz J, Payne JM, Pardej S, de Blank P, Kennedy T, Janke KM, Castillo AD, Walsh KS. Recommendations for Measurement of Attention Outcomes in Preschoolers With Neurofibromatosis. Neurology 2021; 97:S81-S90. [PMID: 34230206 DOI: 10.1212/wnl.0000000000012423] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/09/2020] [Accepted: 04/30/2021] [Indexed: 11/15/2022] Open
Abstract
Children with neurofibromatosis type 1 (NF1) are at increased risk for attention problems. While most research has been conducted with school-aged cohorts, preschool-aged children offer a novel developmental window for clinical studies, with the promise that treatments implemented earlier in the developmental trajectory may most effectively modify risk for later difficulties. Designing research studies around the youngest children with NF1 can result in intervention earlier in the developmental cascade associated with NF1 gene abnormalities. Furthermore, clinical trials for medications targeting physical and psychological aspects of NF1 often include individuals spanning a wide age range, including preschool-aged children. In a prior report, the REiNS Neurocognitive Subcommittee made recommendations regarding performance-based and observer-rated measures of attention for use in clinical trials and highlighted the need for separate consideration of assessment methods for young children. The observer-rated Attention-Deficit/Hyperactivity Disorder Rating Scale-Preschool version is recommended as a primary outcome measure. The NIH Toolbox Flanker, Dimensional Change Card Sort, and List Sort Working Memory tasks and Digits Forward from the Differential Ability Scales-2nd Edition (performance-based measures) are recommended as secondary outcome measures. Specific methodologic recommendations for inclusion of preschoolers in clinical trials research are also offered.
Collapse
Affiliation(s)
- Bonita P Klein-Tasman
- From the Department of Psychology (B.P.K.-T., K.L., S.P.), University of Wisconsin-Milwaukee; Department of Communication Sciences and Disorders (H.L.T.), California State University, Sacramento; University of Colorado School of Medicine (J.J.), Aurora; Murdoch Children's Research Institute and Department of Pediatrics (J.M.P.), University of Melbourne, Australia; University of Cincinnati Medical Center (P.d.B.), OH; Children's National Hospital (T.K., A.d.C., K.S.W.), Gilbert NF Institute, Washington, DC; and Division of Oncology (K.M.J.), Children's Hospital of Philadelphia, PA.
| | - Kristin Lee
- From the Department of Psychology (B.P.K.-T., K.L., S.P.), University of Wisconsin-Milwaukee; Department of Communication Sciences and Disorders (H.L.T.), California State University, Sacramento; University of Colorado School of Medicine (J.J.), Aurora; Murdoch Children's Research Institute and Department of Pediatrics (J.M.P.), University of Melbourne, Australia; University of Cincinnati Medical Center (P.d.B.), OH; Children's National Hospital (T.K., A.d.C., K.S.W.), Gilbert NF Institute, Washington, DC; and Division of Oncology (K.M.J.), Children's Hospital of Philadelphia, PA
| | - Heather L Thompson
- From the Department of Psychology (B.P.K.-T., K.L., S.P.), University of Wisconsin-Milwaukee; Department of Communication Sciences and Disorders (H.L.T.), California State University, Sacramento; University of Colorado School of Medicine (J.J.), Aurora; Murdoch Children's Research Institute and Department of Pediatrics (J.M.P.), University of Melbourne, Australia; University of Cincinnati Medical Center (P.d.B.), OH; Children's National Hospital (T.K., A.d.C., K.S.W.), Gilbert NF Institute, Washington, DC; and Division of Oncology (K.M.J.), Children's Hospital of Philadelphia, PA
| | - Jennifer Janusz
- From the Department of Psychology (B.P.K.-T., K.L., S.P.), University of Wisconsin-Milwaukee; Department of Communication Sciences and Disorders (H.L.T.), California State University, Sacramento; University of Colorado School of Medicine (J.J.), Aurora; Murdoch Children's Research Institute and Department of Pediatrics (J.M.P.), University of Melbourne, Australia; University of Cincinnati Medical Center (P.d.B.), OH; Children's National Hospital (T.K., A.d.C., K.S.W.), Gilbert NF Institute, Washington, DC; and Division of Oncology (K.M.J.), Children's Hospital of Philadelphia, PA
| | - Jonathan M Payne
- From the Department of Psychology (B.P.K.-T., K.L., S.P.), University of Wisconsin-Milwaukee; Department of Communication Sciences and Disorders (H.L.T.), California State University, Sacramento; University of Colorado School of Medicine (J.J.), Aurora; Murdoch Children's Research Institute and Department of Pediatrics (J.M.P.), University of Melbourne, Australia; University of Cincinnati Medical Center (P.d.B.), OH; Children's National Hospital (T.K., A.d.C., K.S.W.), Gilbert NF Institute, Washington, DC; and Division of Oncology (K.M.J.), Children's Hospital of Philadelphia, PA
| | - Sara Pardej
- From the Department of Psychology (B.P.K.-T., K.L., S.P.), University of Wisconsin-Milwaukee; Department of Communication Sciences and Disorders (H.L.T.), California State University, Sacramento; University of Colorado School of Medicine (J.J.), Aurora; Murdoch Children's Research Institute and Department of Pediatrics (J.M.P.), University of Melbourne, Australia; University of Cincinnati Medical Center (P.d.B.), OH; Children's National Hospital (T.K., A.d.C., K.S.W.), Gilbert NF Institute, Washington, DC; and Division of Oncology (K.M.J.), Children's Hospital of Philadelphia, PA
| | - Peter de Blank
- From the Department of Psychology (B.P.K.-T., K.L., S.P.), University of Wisconsin-Milwaukee; Department of Communication Sciences and Disorders (H.L.T.), California State University, Sacramento; University of Colorado School of Medicine (J.J.), Aurora; Murdoch Children's Research Institute and Department of Pediatrics (J.M.P.), University of Melbourne, Australia; University of Cincinnati Medical Center (P.d.B.), OH; Children's National Hospital (T.K., A.d.C., K.S.W.), Gilbert NF Institute, Washington, DC; and Division of Oncology (K.M.J.), Children's Hospital of Philadelphia, PA
| | - Tess Kennedy
- From the Department of Psychology (B.P.K.-T., K.L., S.P.), University of Wisconsin-Milwaukee; Department of Communication Sciences and Disorders (H.L.T.), California State University, Sacramento; University of Colorado School of Medicine (J.J.), Aurora; Murdoch Children's Research Institute and Department of Pediatrics (J.M.P.), University of Melbourne, Australia; University of Cincinnati Medical Center (P.d.B.), OH; Children's National Hospital (T.K., A.d.C., K.S.W.), Gilbert NF Institute, Washington, DC; and Division of Oncology (K.M.J.), Children's Hospital of Philadelphia, PA
| | - Kelly M Janke
- From the Department of Psychology (B.P.K.-T., K.L., S.P.), University of Wisconsin-Milwaukee; Department of Communication Sciences and Disorders (H.L.T.), California State University, Sacramento; University of Colorado School of Medicine (J.J.), Aurora; Murdoch Children's Research Institute and Department of Pediatrics (J.M.P.), University of Melbourne, Australia; University of Cincinnati Medical Center (P.d.B.), OH; Children's National Hospital (T.K., A.d.C., K.S.W.), Gilbert NF Institute, Washington, DC; and Division of Oncology (K.M.J.), Children's Hospital of Philadelphia, PA
| | - Allison Del Castillo
- From the Department of Psychology (B.P.K.-T., K.L., S.P.), University of Wisconsin-Milwaukee; Department of Communication Sciences and Disorders (H.L.T.), California State University, Sacramento; University of Colorado School of Medicine (J.J.), Aurora; Murdoch Children's Research Institute and Department of Pediatrics (J.M.P.), University of Melbourne, Australia; University of Cincinnati Medical Center (P.d.B.), OH; Children's National Hospital (T.K., A.d.C., K.S.W.), Gilbert NF Institute, Washington, DC; and Division of Oncology (K.M.J.), Children's Hospital of Philadelphia, PA
| | - Karin S Walsh
- From the Department of Psychology (B.P.K.-T., K.L., S.P.), University of Wisconsin-Milwaukee; Department of Communication Sciences and Disorders (H.L.T.), California State University, Sacramento; University of Colorado School of Medicine (J.J.), Aurora; Murdoch Children's Research Institute and Department of Pediatrics (J.M.P.), University of Melbourne, Australia; University of Cincinnati Medical Center (P.d.B.), OH; Children's National Hospital (T.K., A.d.C., K.S.W.), Gilbert NF Institute, Washington, DC; and Division of Oncology (K.M.J.), Children's Hospital of Philadelphia, PA
| | | |
Collapse
|
9
|
Traunwieser T, Kandels D, Pauls F, Pietsch T, Warmuth-Metz M, Bison B, Krauss J, Kortmann RD, Timmermann B, Thomale UW, Luettich P, Neumann-Holbeck A, Tischler T, Hernáiz Driever P, Witt O, Gnekow AK. Long-term cognitive deficits in pediatric low-grade glioma (LGG) survivors reflect pretreatment conditions-report from the German LGG studies. Neurooncol Adv 2020; 2:vdaa094. [PMID: 32968720 PMCID: PMC7497816 DOI: 10.1093/noajnl/vdaa094] [Citation(s) in RCA: 10] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
Abstract
Background Disease and treatment contribute to cognitive late effects following pediatric low-grade glioma (LGG). We analyzed prospectively collected neuropsychological data of German pediatric LGG survivors and focused on the impact of hydrocephalus at diagnosis, neurofibromatosis type 1 (NF1) status, and extent of surgery. Methods We used the Neuropsychological Basic Diagnostic screening tool based on the Cattell-Horn-Carroll model for intelligence and the concept of cross-battery assessment at 2 and 5 years from diagnosis for 316 patients from the German pediatric LGG study and LGG registry (7.1 years median age; 45 NF1; cerebral hemispheres 16%, supratentorial midline 39%, infratentorial 45%). Hydrocephalus was classified radiologically in 137 non-NF1 patients with infratentorial tumors (95/137 complete/subtotal resection). Results Patients with NF1 versus non-NF1 exhibited inferior verbal short-term memory and visual processing (P < .001-.021). In non-NF1 patients, infratentorial tumor site and complete/subtotal resection were associated with sequelae in visual processing, psychomotor speed, and processing speed (P < .001-.008). Non-NF1 patients without surgical tumor reduction and/or nonsurgical treatment experienced similar deficits. Degree of hydrocephalus at diagnosis had no further impact. Psychomotor and processing speed were impaired comparably following chemo-/radiotherapy (P < .001-.021). Pretreatment factors such as NF1 or tumor site were relevant at multivariate analysis. Conclusions All pediatric LGG survivors are at risk to experience long-term cognitive impairments in various domains. Even surgical only management of cerebellar LGG or no treatment at all, that is, biopsy only/radiological diagnosis did not protect cognitive function. Since pattern and extent of deficits are crucial to tailor rehabilitation, neuropsychological and quality of survival assessments should be mandatory in future LGG trials.
Collapse
Affiliation(s)
- Thomas Traunwieser
- Paediatrics and Adolescent Medicine, Medical Faculty, University of Augsburg, Augsburg, Germany
| | - Daniela Kandels
- Paediatrics and Adolescent Medicine, Medical Faculty, University of Augsburg, Augsburg, Germany
| | - Franz Pauls
- Department of Clinical Psychology, Helmut Schmidt University, Hamburg, Germany
| | - Torsten Pietsch
- Institute of Neuropathology, DGNN Brain Tumor Reference Center, University Bonn, Bonn, Germany
| | - Monika Warmuth-Metz
- Institute of Diagnostic and Interventional Neuroradiology, University Hospital Wuerzburg, Wuerzburg, Germany
| | - Brigitte Bison
- Institute of Diagnostic and Interventional Neuroradiology, University Hospital Wuerzburg, Wuerzburg, Germany
| | - Juergen Krauss
- Section of Pediatric Neurosurgery, University Hospital Wuerzburg, Wuerzburg, Germany
| | | | - Beate Timmermann
- Department of Particle Therapy, University Hospital Essen, West German Proton Therapy Centre Essen (WPE), West German Cancer Center (WTZ), German Cancer Consortium (DKTK), Essen, Germany
| | | | - Peggy Luettich
- Hopp Children's Cancer Center Heidelberg (KiTZ), German Cancer Research Center (DKFZ) and Heidelberg University Hospital, Heidelberg, Germany
| | | | - Tanja Tischler
- University Medical Center Hamburg-Eppendorf, Hamburg, Germany
| | - Pablo Hernáiz Driever
- Department of Pediatric Oncology/Hematology, Charité-Universitaetsmedizin Berlin, Corporate member of Freie Universitaet Berlin, Humboldt-Universitaet zu Berlin, and Berlin Institute of Health, Berlin, Germany
| | - Olaf Witt
- Hopp Children's Cancer Center Heidelberg (KiTZ), German Cancer Research Center (DKFZ) and Heidelberg University Hospital, Heidelberg, Germany
| | - Astrid K Gnekow
- Paediatrics and Adolescent Medicine, Medical Faculty, University of Augsburg, Augsburg, Germany
| |
Collapse
|
10
|
Cohen R, Halevi A, Aharoni S, Aronson B, Diamond G. Impairments in communication and social interaction in children with neurofibromatosis type 1: Characteristics and role of ADHD and language delay. APPLIED NEUROPSYCHOLOGY. CHILD 2020; 11:220-225. [PMID: 32569512 DOI: 10.1080/21622965.2020.1780924] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 10/24/2022]
Abstract
Background: Neurofibromatosis type 1 (NF1) is a multisystem neurocutaneous disorder with increased risk of tumor formation and higher incidence of autism spectrum disorder (ASD) than the general population. The aim of the study was to assess the presence of ASD symptoms in young children with NF1 and to examine their potential association with attention deficit hyperactivity disorder (ADHD) and speech delay.Methods: The cohort included 30 patients with NF1 attending the multidisciplinary NF1 clinic of a tertiary pediatric medical center from September 2015 through September 2016. The parents/caregivers completed the Social Communication Questionnaire (SCQ) and the Vineland Adaptive Behavior Scales (VABS II).Results: Sixteen patients (53%) had a previous diagnosis of ADHD. There was a positive association between the presence of ADHD and a low score on the VABS II interpersonal relationships subscale of the Socialization domain. Language delay, documented in 12 children (40%), also correlated with a low interpersonal relationships score.Conclusions: ADHD appears to be more a marker than an actual independent risk factor of ASD in NF1. The early evaluation of children with NF1 for interpersonal communication problems and ASD, especially those with a speech delay or ADHD, will alert clinicians to initiate appropriate and timely treatment.
Collapse
Affiliation(s)
- Rony Cohen
- Department of Pediatric Neurology and Epilepsy Center, Schneider Children's Medical Center of Israel, Petach Tikva, Israel.,Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
| | - Ayelet Halevi
- Department of Pediatric Neurology and Epilepsy Center, Schneider Children's Medical Center of Israel, Petach Tikva, Israel.,Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
| | - Sharon Aharoni
- Department of Pediatric Neurology and Epilepsy Center, Schneider Children's Medical Center of Israel, Petach Tikva, Israel.,Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
| | - Bosmat Aronson
- The Child Development and Rehabilitation Institute, Schneider Children's Medical Center of Israel, Petach Tikva, Israel.,Department of Developmental and Educational Psychology, Clalit Health Services, Tel Aviv, Israel
| | - Gary Diamond
- Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.,The Child Development and Rehabilitation Institute, Schneider Children's Medical Center of Israel, Petach Tikva, Israel
| |
Collapse
|
11
|
Pierpont EI, Hudock RL, Foy AM, Semrud-Clikeman M, Pierpont ME, Berry SA, Shanley R, Rubin N, Sommer K, Moertel CL. Social skills in children with RASopathies: a comparison of Noonan syndrome and neurofibromatosis type 1. J Neurodev Disord 2018; 10:21. [PMID: 29914349 PMCID: PMC6006579 DOI: 10.1186/s11689-018-9239-8] [Citation(s) in RCA: 23] [Impact Index Per Article: 3.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 01/27/2018] [Accepted: 06/04/2018] [Indexed: 12/12/2022] Open
Abstract
Background Gene mutations within the RAS-MAPK signaling cascade result in Noonan syndrome (NS), neurofibromatosis type 1 (NF1), and related disorders. Recent research has documented an increased risk for social difficulties and features of autism spectrum disorder (ASD) among children with these conditions. Despite this emerging evidence, the neuropsychological characteristics associated with social skills deficits are not well understood, particularly for children with NS. Methods Parents of children with NS (n = 39), NF1 (n = 39), and unaffected siblings (n = 32) between the ages of 8 and 16 years were administered well-validated caregiver questionnaires assessing their child’s social skills, language abilities, attention-deficit hyperactivity disorder (ADHD) symptoms and anxiety. Results With respect to overall social skills, average ratings of children in both clinical groups were similar, and indicated weaker social skills compared to unaffected siblings. Although ratings of social skills were outside of normal limits for more than four in ten children within the clinical groups, most of the deficits were mild/moderate. Fifteen percent of the children with NS and 5% of the children with NF1 were rated as having severe social skills impairment (< − 2SD). Independent of diagnosis, having fewer ADHD symptoms or better social-pragmatic language skills was predictive of stronger social skills. Conclusions Amidst efforts to support social skill development among children and adolescents with RASopathies, neuropsychological correlates such as social language competence, attention, and behavioral self-regulation could be important targets of intervention.
Collapse
Affiliation(s)
- Elizabeth I Pierpont
- Division of Clinical Behavioral Neuroscience, Department of Pediatrics, University of Minnesota, 420 Delaware Street SE, Mayo Mail Code 486, Minneapolis, MN, 55455, USA.
| | - Rebekah L Hudock
- Division of Clinical Behavioral Neuroscience, Department of Pediatrics, University of Minnesota, 420 Delaware Street SE, Mayo Mail Code 486, Minneapolis, MN, 55455, USA
| | - Allison M Foy
- Division of Clinical Behavioral Neuroscience, Department of Pediatrics, University of Minnesota, 420 Delaware Street SE, Mayo Mail Code 486, Minneapolis, MN, 55455, USA
| | - Margaret Semrud-Clikeman
- Division of Clinical Behavioral Neuroscience, Department of Pediatrics, University of Minnesota, 420 Delaware Street SE, Mayo Mail Code 486, Minneapolis, MN, 55455, USA
| | - Mary Ella Pierpont
- Division of Genetics & Metabolism, Department of Pediatrics and Ophthalmology, University of Minnesota, 2450 Riverside Avenue, Minneapolis, MN, 55455, USA
| | - Susan A Berry
- Division of Genetics & Metabolism, Department of Pediatrics and Ophthalmology, University of Minnesota, 2450 Riverside Avenue, Minneapolis, MN, 55455, USA
| | - Ryan Shanley
- Biostatistics Core, University of Minnesota, 717 Delaware Street SE, Minneapolis, MN, 55414, USA
| | - Nathan Rubin
- Biostatistics Core, University of Minnesota, 717 Delaware Street SE, Minneapolis, MN, 55414, USA
| | - Katherine Sommer
- University of Minnesota Health, 2450 Riverside Avenue, Minneapolis, MN, 55455, USA
| | - Christopher L Moertel
- Division of Pediatric Hematology and Oncology, Department of Pediatrics, University of Minnesota, Mayo Mail Code 484, 420 Delaware Street SE, Mayo Mail Code 486, Minneapolis, MN, 55455, USA
| |
Collapse
|
12
|
Garg S, Green J. Studying child development in genetic models of ASD. PROGRESS IN BRAIN RESEARCH 2018; 241:159-192. [DOI: 10.1016/bs.pbr.2018.09.009] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 01/07/2023]
|
13
|
Kolesnik AM, Jones EJH, Garg S, Green J, Charman T, Johnson MH. Early development of infants with neurofibromatosis type 1: a case series. Mol Autism 2017; 8:62. [PMID: 29204259 PMCID: PMC5701449 DOI: 10.1186/s13229-017-0178-0] [Citation(s) in RCA: 46] [Impact Index Per Article: 5.8] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/03/2017] [Accepted: 10/31/2017] [Indexed: 12/26/2022] Open
Abstract
Background Prospective studies of infants at familial risk for autism spectrum disorder (ASD) have yielded insights into the earliest signs of the disorder but represent heterogeneous samples of unclear aetiology. Complementing this approach by studying cohorts of infants with monogenic syndromes associated with high rates of ASD offers the opportunity to elucidate the factors that lead to ASD. Methods We present the first report from a prospective study of ten 10-month-old infants with neurofibromatosis type 1 (NF1), a monogenic disorder with high prevalence of ASD or ASD symptomatology. We compared data from infants with NF1 to a large cohort of infants at familial risk for ASD, separated by outcome at age 3 of ASD (n = 34), atypical development (n = 44), or typical development (n = 89), and low-risk controls (n = 75). Domains assessed at 10 months by parent report and examiner observation include cognitive and adaptive function, sensory processing, social engagement, and temperament. Results Infants with NF1 showed striking impairments in motor functioning relative to low-risk infants; this pattern was seen in infants with later ASD from the familial cohort (HR-ASD). Both infants with NF1 and the HR-ASD group showed communication delays relative to low-risk infants. Conclusions Ten-month-old infants with NF1 show a range of developmental difficulties that were particularly striking in motor and communication domains. As with HR-ASD infants, social skills at this age were not notably impaired. This is some of the first information on early neurodevelopment in NF1. Strong inferences are limited by the sample size, but the findings suggest implications for early comparative developmental science and highlight motor functioning as an important domain to inform the development of relevant animal models. The findings have clinical implications in indicating an important focus for early surveillance and remediation in this early diagnosed genetic disorder.
Collapse
Affiliation(s)
- Anna May Kolesnik
- Centre for Brain and Cognitive Development and Department of Psychology, Birkbeck, University of London, Malet Street, London, WC1E 7HX UK
| | - Emily Jane Harrison Jones
- Centre for Brain and Cognitive Development and Department of Psychology, Birkbeck, University of London, Malet Street, London, WC1E 7HX UK
| | - Shruti Garg
- Neuroscience & Experimental Psychology, Manchester Academic Health Science Centre, University of Manchester and Royal Manchester Children’s Hospital, Central Manchester University Hospitals NHS Foundation, Manchester, UK
| | - Jonathan Green
- Neuroscience & Experimental Psychology, Manchester Academic Health Science Centre, University of Manchester and Royal Manchester Children’s Hospital, Central Manchester University Hospitals NHS Foundation, Manchester, UK
| | - Tony Charman
- Department of Psychology, Institute of Psychiatry, Psychology & Neuroscience, King’s College London, London, UK
| | - Mark Henry Johnson
- Centre for Brain and Cognitive Development and Department of Psychology, Birkbeck, University of London, Malet Street, London, WC1E 7HX UK
| |
Collapse
|
14
|
Bilder DA, Bakian AV, Stevenson DA, Carbone PS, Cunniff C, Goodman AB, McMahon WM, Fisher NP, Viskochil D. Brief Report: The Prevalence of Neurofibromatosis Type 1 among Children with Autism Spectrum Disorder Identified by the Autism and Developmental Disabilities Monitoring Network. J Autism Dev Disord 2017; 46:3369-76. [PMID: 27465244 DOI: 10.1007/s10803-016-2877-3] [Citation(s) in RCA: 10] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/21/2022]
Abstract
Neurofibromatosis type 1 (NF1) is an inherited neurocutaneous disorder associated with neurodevelopmental disorders including autism spectrum disorder (ASD). The frequency of ASD/NF1 co-occurrence has been subject to debate since the 1980s. This relationship was investigated in a large population-based sample of 8-year-old children identified with ASD (N = 12,271) by the Centers for Disease Control and Prevention's Autism and Developmental Disabilities Monitoring (ADDM) Network. Twenty-two (1-in-558) children with ASD had diagnosed NF1, exceeding NF1 general population estimates by four to five fold. Children with ASD/NF1 versus ASD without NF1 were significantly less likely to receive a community-based ASD diagnosis (p = 0.04) and understand non-verbal communication (p = 0.001). These findings underscore the importance of including social-communication ability among relevant developmental concerns in children with NF1.
Collapse
Affiliation(s)
- Deborah A Bilder
- Utah Autism Research Program, Department of Psychiatry, University of Utah, 650 Komas Drive, Suite 206, Salt Lake City, UT, 84108, USA.
| | - Amanda V Bakian
- Utah Autism Research Program, Department of Psychiatry, University of Utah, 650 Komas Drive, Suite 206, Salt Lake City, UT, 84108, USA
| | - David A Stevenson
- Division of Medical Genetics, University of Utah, Salt Lake City, UT, USA.,Division of Medical Genetics, Stanford University, California, USA
| | - Paul S Carbone
- Department of Pediatrics, University of Utah, Salt Lake City, UT, USA
| | - Christopher Cunniff
- Department of Pediatrics, University of Arizona, Tucson, AZ, USA.,Division of Medical Genetics, Weill Cornell Medical College, New York, USA
| | - Alyson B Goodman
- National Center on Birth Defects and Developmental Disabilities, Center for Disease Control and Prevention, Atlanta, GA, USA
| | - William M McMahon
- Department of Psychiatry, University of Utah, Salt Lake City, UT, USA
| | - Nicole P Fisher
- Department of Psychiatry, University of Utah, Salt Lake City, UT, USA
| | - David Viskochil
- Division of Medical Genetics, University of Utah, Salt Lake City, UT, USA
| |
Collapse
|
15
|
Rietman AB, Oostenbrink R, van Noort K, Franken MCJP, Catsman-Berrevoets CE, Aarsen FK, Hendriksen JG, de Nijs PFA. Development of emotional and behavioral problems in neurofibromatosis type 1 during young childhood. Am J Med Genet A 2017. [DOI: 10.1002/ajmg.a.38323] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/09/2022]
Affiliation(s)
- André B. Rietman
- Department of Pediatric Neurology; Erasmus MC-Sophia Children's Hospital and ENCORE Expertise Centre for Neurodevelopmental Disorders; Rotterdam The Netherlands
| | - Rianne Oostenbrink
- Department of General Pediatrics; Erasmus MC-Sophia Children's Hospital and ENCORE Expertise Centre for Neurodevelopmental Disorders; Rotterdam The Netherlands
| | - Kimberley van Noort
- Department of Pediatric Neurology; Erasmus MC-Sophia Children's Hospital and ENCORE Expertise Centre for Neurodevelopmental Disorders; Rotterdam The Netherlands
| | - Marie-Christine J. P. Franken
- Department of Otorhinolaryngology; Erasmus MC-Sophia Children's Hospital and ENCORE Expertise Centre for Neurodevelopmental Disorders; Rotterdam The Netherlands
| | - Coriene E. Catsman-Berrevoets
- Department of Pediatric Neurology; Erasmus MC-Sophia Children's Hospital and ENCORE Expertise Centre for Neurodevelopmental Disorders; Rotterdam The Netherlands
| | - Femke K. Aarsen
- Department of Pediatric Neurology; Erasmus MC-Sophia Children's Hospital and ENCORE Expertise Centre for Neurodevelopmental Disorders; Rotterdam The Netherlands
| | - Jos G. Hendriksen
- Center for Neurological Learning Disorders; Kempenhaeghe Expertise Centre for Epilepsy, Sleeping Problems and Neurocognitive Disorders; Heeze The Netherlands
| | - Pieter F. A. de Nijs
- Department of Child and Adolescent Psychiatry/Psychology; Erasmus MC-Sophia Children's Hospital and ENCORE Expertise Centre for Neurodevelopmental Disorders; Rotterdam The Netherlands
| |
Collapse
|
16
|
Casnar CL, Klein-Tasman BP. Parent and Teacher Perspectives on Emerging Executive Functioning in Preschoolers With Neurofibromatosis Type 1: Comparison to Unaffected Children and Lab-Based Measures. J Pediatr Psychol 2017; 42:198-207. [PMID: 27189686 DOI: 10.1093/jpepsy/jsw042] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/24/2015] [Accepted: 04/19/2016] [Indexed: 11/12/2022] Open
Abstract
Objective Children with neurofibromatosis type 1 (NF1) are at risk for executive functioning (EF) challenges, with little research with preschoolers. Methods EF was examined using parent and teacher ratings of preschool-aged children with NF1 ( n = 26) and parent ratings of unaffected children ( n = 37) on the Behavior Rating Inventory for Executive Functioning-Preschool Form. Relations to performance on laboratory measures were also examined. Results Based on parent ratings, children with NF1 had more dysfunction than the normative mean on the Working Memory (WM) scale and Emergent Metacognition Index (EMI). Teacher ratings indicated greater dysfunction than the normative mean on the WM and Planning/Organization scales, EMI, and General Executive Composite. Children with NF1 showed more difficulties than unaffected children on the WM scale. Teacher report of WM was significantly correlated with Differential Ability Scales-Second Edition Digits Forward performance. Conclusions WM emerged as an area of difficulty for young children with NF1.
Collapse
Affiliation(s)
- Christina L Casnar
- Department of Psychology, University of Wisconsin-Milwaukee, Milwaukee, WI, USA
| | | |
Collapse
|
17
|
Torres Nupan MM, Velez Van Meerbeke A, López Cabra CA, Herrera Gomez PM. Cognitive and Behavioral Disorders in Children with Neurofibromatosis Type 1. Front Pediatr 2017; 5:227. [PMID: 29164079 PMCID: PMC5670111 DOI: 10.3389/fped.2017.00227] [Citation(s) in RCA: 61] [Impact Index Per Article: 7.6] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 06/06/2017] [Accepted: 10/05/2017] [Indexed: 11/13/2022] Open
Abstract
AIM The last systematic review of research on the behavior of children with neurofibromatosis type 1 (NF1) was in 2012. Since then, several important findings have been published. Therefore, the study aim was to synthesize recent relevant work related to this issue. METHOD We conducted a systematic review of the literature. Relevant articles were identified using the electronic databases PubMed, PsycINFO, and Scopus and a manual search of references lists. Thirty of 156 articles identified met the inclusion criteria. A quality evaluation of the articles was performed and the information was synthesized using a narrative approach. RESULTS Compared with controls, children and adolescents with NF1 present significant alterations in language, reading, visuospatial skills, motor function, executive function, attention, behavior, emotion, and social skills. The prevalence of attention-deficit/hyperactivity disorder (ADHD) is important and can affect cognition and executive function variables. A high prevalence of autistic traits and autistic spectrum disorder were reported. The benefits of using statins to treat cognitive deficits are unclear. However, children with NF1 and ADHD seem to benefit from methylphenidate treatment. The presence of hyperintensities in brain magnetic resonance imaging data seem to be related to poor cognitive performance. Analysis of these lesions could help to predict cognitive alterations in children with NF1. INTERPRETATION There has been important progress to evaluate cognitive characteristics of children with NF1 and to determine the physiological mechanisms of the concomitant disorders. However, discrepancies in relation to intelligence, learning disabilities, attention deficits, and treatment remain. Further investigations on this topic are recommended.
Collapse
Affiliation(s)
- Martha Milade Torres Nupan
- Neurosciences Research Group, Medicine and Health Sciences School, Universidad del Rosario, Bogota, Colombia
| | - Alberto Velez Van Meerbeke
- Neurosciences Research Group, Medicine and Health Sciences School, Universidad del Rosario, Bogota, Colombia
| | | | - Paula Marcela Herrera Gomez
- Neurosciences Research Group, Medicine and Health Sciences School, Universidad del Rosario, Bogota, Colombia
| |
Collapse
|